ICGEB makes great effort to promote Women in Science. The latest initiative has been carried out thanks to the support of the United Nations Office for South-South Cooperation. Five women scientists will be granted a six-month fellowship to work on their research at the ICGEB components in New Delhi and Cape Town.
The EMPOWER project has been launched to promote early-career women scientists from developing countries. It is an effective South-South Triangular Cooperation programme to foster careers and strengthen the expertise of young researchers from developing countries from South America, Africa and South Asia. The project is under the umbrella of the Youth4South initiative of the United Nations Office for South-South Cooperation (UNOSSC) and was designed to promote youth leadership and capacity development for achieving the sustainable development goals of quality education (SDG4) and gender equality (SDG5).
The programme was launched last summer and now the awardees have been selected and are ready to move to the respective ICGEB components in New Delhi and Cape Town. There, ICGEB scientists will offer labs, expertise and know-how to host these scientists for a six-month period in several fields of biotechnology, from infectious diseases and non-communicable diseases to sustainable agriculture and industrial biotechnology.
Ruvarashe Loveness Mhuruyengwe
is from Zimbabwe and will move to Cape Town to investigate the genetic characteristics of Sorghum cultivars able to tolerate drought.
Lida Carolina Lesmes Rodriguez
will move from Colombia to Cape Town to study the influence of common human coronaviruses on the immune system in COVID-19 patients.
is from Bangladesh and will move to New Delhi to design and develop new antimalarial drug compounds.
Maria Mgella Zinga
from Tanzania will spend her fellowship in Cape Town to identify new possible biomarkers for Plasmodium falciparum infections to enhance the potential to detect malaria cases.
Opeyemi De Campos
will move from Nigeria to Cape Town to study new possibilities for an improved and effective therapy of prostate cancer.